Schrodinger (SDGR) Stock Price, News & Analysis

Company Overview

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Key Stats

• Today's Range: $19.47 to $20.23
• 50-Day Range: $19.53 to $26.69
• 52-Week Range: $16.60 to $28.47
• Volume: 1.12 million shs
• Average Volume: 942,510 shs
• Market Capitalization: $1.43 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $32.75
• Consensus Rating: Moderate Buy

Schrodinger Stock Analysis - MarketRank™

Schrodinger scored higher than 52% of companies evaluated by MarketBeat, and ranked 489th out of 919 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Schrodinger has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Schrodinger has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Schrodinger are expected to grow in the coming year, from ($2.37) to ($2.08) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Schrodinger is -7.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Schrodinger is -7.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Schrodinger has a P/B Ratio of 3.38. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

15.14% of the outstanding shares of Schrodinger have been sold short.

Short Interest Ratio / Days to Cover

Schrodinger has a short interest ratio ("days to cover") of 9.7.

Change versus previous month

Short interest in Schrodinger has recently decreased by 0.45%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Schrodinger does not currently pay a dividend.

Dividend Growth

Schrodinger does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

15.14% of the outstanding shares of Schrodinger have been sold short.

Short Interest Ratio / Days to Cover

Schrodinger has a short interest ratio ("days to cover") of 9.7.

Change versus previous month

Short interest in Schrodinger has recently decreased by 0.45%, indicating that investor sentiment is improving.

News and Social Media

• Score: 3.5 / 5
• News Sentiment: 1.30

News Sentiment

Schrodinger has a news sentiment score of 1.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.45 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 5 news articles for Schrodinger this week, compared to 4 articles on an average week.

Search Interest

Only 8 people have searched for SDGR on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.

MarketBeat Follows

9 people have added Schrodinger to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Schrodinger insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 8.60% of the stock of Schrodinger is held by insiders.

Percentage Held by Institutions

79.05% of the stock of Schrodinger is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

SDGR Stock Analysis - Frequently Asked Questions

How have SDGR shares performed this year?

Schrodinger's stock was trading at $19.29 at the beginning of the year. Since then, SDGR stock has increased by 1.2% and is now trading at $19.53.

How were Schrodinger's earnings last quarter?

Schrodinger, Inc. (NASDAQ:SDGR) announced its quarterly earnings results on Wednesday, May, 7th. The company reported ($0.82) earnings per share for the quarter, missing the consensus estimate of ($0.81) by $0.01. Schrodinger's revenue was up 62.7% on a year-over-year basis.
Read the conference call transcript.

When did Schrodinger IPO?

Schrodinger (SDGR) raised $150 million in an initial public offering on Thursday, February 6th 2020. The company issued 10,000,000 shares at $14.00-$16.00 per share. Morgan Stanley, BofA Securities, Jefferies and BMO Capital Markets served as the underwriters for the IPO.

Who are Schrodinger's major shareholders?

Top institutional investors of Schrodinger include Sumitomo Mitsui Trust Group Inc. (4.97%), Stephens Investment Management Group LLC (3.08%), ARK Investment Management LLC (2.67%) and Allspring Global Investments Holdings LLC (0.28%). Insiders that own company stock include Ramy Farid, Kenneth Patrick Lorton, Geoffrey Craig Porges, Karen Akinsanya, Margaret Dugan, Yvonne Tran, Jenny Herman, Robert Lorne Abel and Nancy Thornberry.
View institutional ownership trends.

How do I buy shares of Schrodinger?

Shares of SDGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Schrodinger own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Schrodinger investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AU Optronics (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

• Last Earnings: 5/07/2025
• Today: 8/02/2025
• Next Earnings (Estimated): 8/06/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MEDICAL INFO SYS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:SDGR
• CIK: 1490978
• Web: www.schrodinger.com
• Phone: 212-295-5800
• Fax: N/A
• Employees: 790
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Schrodinger: $32.75
• High Price Target: $45.00
• Low Price Target: $28.00
• Potential Upside/Downside: +67.7%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.75
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): ($2.63)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$187.12 million
• Net Margins: -83.39%
• Pretax Margin: -82.96%
• Return on Equity: -44.74%
• Return on Assets: -26.29%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.45
• Quick Ratio: 3.45

Sales & Book Value

• Annual Sales: $207.54 million
• Price / Sales: 6.91
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $5.78 per share
• Price / Book: 3.38

Miscellaneous

• Outstanding Shares: 73,380,000
• Free Float: 67,067,000
• Market Cap: $1.43 billion
• Optionable: Optionable
• Beta: 1.67